UniProt ID | TIMP1_HUMAN | |
---|---|---|
UniProt AC | P01033 | |
Protein Name | Metalloproteinase inhibitor 1 | |
Gene Name | TIMP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 207 | |
Subcellular Localization | Secreted . | |
Protein Description | Metalloproteinase inhibitor that functions by forming one to one complexes with target metalloproteinases, such as collagenases, and irreversibly inactivates them by binding to their catalytic zinc cofactor. Acts on MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 and MMP16. Does not act on MMP14. Also functions as a growth factor that regulates cell differentiation, migration and cell death and activates cellular signaling cascades via CD63 and ITGB1. Plays a role in integrin signaling. Mediates erythropoiesis in vitro; but, unlike IL3, it is species-specific, stimulating the growth and differentiation of only human and murine erythroid progenitors.. | |
Protein Sequence | MAPFEPLASGILLLLWLIAPSRACTCVPPHPQTAFCNSDLVIRAKFVGTPEVNQTTLYQRYEIKMTKMYKGFQALGDAADIRFVYTPAMESVCGYFHRSHNRSEEFLIAGKLQDGLLHITTCSFVAPWNSLSLAQRRGFTKTYTVGCEECTVFPCLSIPCKLQSGTHCLWTDQLLQGSEKGFQSRHLACLPREPGLCTWQSLRSQIA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | IAPSRACTCVPPHPQ HCCCCCCCCCCCCCC | 18.62 | 26091039 | |
45 | Ubiquitination | SDLVIRAKFVGTPEV CCEEEEEEECCCCCC | 30.63 | 21906983 | |
49 | Phosphorylation | IRAKFVGTPEVNQTT EEEEECCCCCCCCCC | 15.80 | 27174698 | |
53 | N-linked_Glycosylation | FVGTPEVNQTTLYQR ECCCCCCCCCCCHHE | 31.64 | 16263699 | |
53 | N-linked_Glycosylation | FVGTPEVNQTTLYQR ECCCCCCCCCCCHHE | 31.64 | 16263699 | |
55 | Phosphorylation | GTPEVNQTTLYQRYE CCCCCCCCCCHHEEE | 17.36 | 27174698 | |
56 | Phosphorylation | TPEVNQTTLYQRYEI CCCCCCCCCHHEEEE | 17.44 | 27174698 | |
58 | Phosphorylation | EVNQTTLYQRYEIKM CCCCCCCHHEEEEEE | 6.72 | 27174698 | |
58 | Nitration | EVNQTTLYQRYEIKM CCCCCCCHHEEEEEE | 6.72 | - | |
61 | Phosphorylation | QTTLYQRYEIKMTKM CCCCHHEEEEEEHHH | 13.38 | 27174698 | |
66 | Phosphorylation | QRYEIKMTKMYKGFQ HEEEEEEHHHCHHHH | 13.99 | 29083192 | |
69 | Phosphorylation | EIKMTKMYKGFQALG EEEEHHHCHHHHHHH | 14.98 | 29083192 | |
70 | Ubiquitination | IKMTKMYKGFQALGD EEEHHHCHHHHHHHC | 50.15 | 2190698 | |
101 | N-linked_Glycosylation | GYFHRSHNRSEEFLI HHHHCCCCCCCEEEE | 50.88 | 16740002 | |
141 | Ubiquitination | AQRRGFTKTYTVGCE HHHCCCCEEEEECCC | 36.95 | - | |
143 | Nitration | RRGFTKTYTVGCEEC HCCCCEEEEECCCCC | 10.86 | - | |
178 | Phosphorylation | TDQLLQGSEKGFQSR EHHHHCCCCCCCCCC | 24.15 | 22427646 | |
180 | Ubiquitination | QLLQGSEKGFQSRHL HHHCCCCCCCCCCEE | 67.72 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
178 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TIMP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TIMP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RECQ5_HUMAN | RECQL5 | physical | 16169070 | |
ECH1_HUMAN | ECH1 | physical | 16169070 | |
EF1B_HUMAN | EEF1B2 | physical | 16169070 | |
MMP3_HUMAN | MMP3 | physical | 9288970 | |
MMP1_HUMAN | MMP1 | physical | 9063449 | |
ZBT16_HUMAN | ZBTB16 | physical | 17340613 | |
PCSK5_MOUSE | Pcsk5 | physical | 16135528 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach."; Lewandrowski U., Moebius J., Walter U., Sickmann A.; Mol. Cell. Proteomics 5:226-233(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53, AND MASS SPECTROMETRY. | |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53 AND ASN-101, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53, AND MASS SPECTROMETRY. |